[Form 4] LXP Industrial Trust Insider Trading Activity

Rhea-AI Filing Summary

Insider transaction disclosure: On 07/03/2025, LXP Industrial Trust (ticker: LXP) director Claire A. Koeneman acquired 3,948 common shares of the company at a reported price of $8.23 per share. Following the purchase, Koeneman directly owns 122,329 common shares of LXP. No derivative securities were involved in this Form 4 filing, and the filing was made solely by the reporting person. The transaction increases the director’s direct equity stake and was not identified as part of a Rule 10b5-1 trading plan.

Positive

• Director purchased 3,948 common shares at $8.23, increasing her direct ownership to 122,329 shares, which can be interpreted as a vote of confidence.

Negative

• None.

Insights

Securities Analyst

TL;DR: Small insider buy; positive signal but likely immaterial to valuation.

The Form 4 shows Director Claire A. Koeneman purchasing 3,948 LXP shares at $8.23, bringing her direct holdings to 122,329 shares. Insider purchases generally indicate confidence, yet the dollar value is modest relative to the REIT’s market capitalization. With no accompanying operational data or earnings update, the filing does not alter fundamental outlook, but it may offer a marginally constructive sentiment cue for investors monitoring insider activity.

Corporate Governance Expert

TL;DR: Governance-neutral filing; routine compliance with Section 16.

The director’s timely Form 4 submission demonstrates adherence to Section 16 reporting requirements. The absence of derivative transactions and the straightforward nature of the common-share purchase suggest standard personal portfolio adjustments rather than strategic board-level signaling. From a governance standpoint, the event is non-controversial and should have negligible impact on shareholder rights or board dynamics.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koeneman Claire A

(Last) (First) (Middle)

C/O LXP INDUSTRIAL TRUST

515 N. FLAGLER DRIVE, SUIT 408

(Street)

WEST PALM BEACH FL 33401

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LXP Industrial Trust [ LXP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	07/03/2025		A		3,948	A	$8.23	122,329	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Claire A. Koeneman, by Joseph S. Bonventre, Attorney-in-Fact	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did LXP (LXP) report on 07/03/2025?

Director Claire A. Koeneman bought 3,948 common shares of LXP Industrial Trust.

At what price were the LXP shares acquired?

The Form 4 lists a purchase price of $8.23 per share.

How many LXP shares does the director now own?

After the transaction, Koeneman directly owns 122,329 common shares.

Were any derivative securities involved in this filing?

No. Table II shows no derivative security transactions.

Was the trade executed under a Rule 10b5-1 plan?

The filing does not indicate that the purchase was made under a Rule 10b5-1(c) trading plan.